BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15695116)

  • 1. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
    Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
    Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvessel density in head and neck squamous cell carcinoma.
    Szafarowski T; Sierdzinski J; Szczepanski MJ; Whiteside TL; Ludwig N; Krzeski A
    Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1845-1851. PubMed ID: 29748768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
    Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
    Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
    Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
    Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
    Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
    APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.
    Kyzas PA; Agnantis NJ; Stefanou D
    Virchows Arch; 2006 Jun; 448(6):768-75. PubMed ID: 16612622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
    Barresi V; Cerasoli S; Vitarelli E; Tuccari G
    Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.
    Pruneri G; Ponzoni M; Ferreri AJ; Decarli N; Tresoldi M; Raggi F; Baldessari C; Freschi M; Baldini L; Goldaniga M; Neri A; Carboni N; Bertolini F; Viale G
    Br J Haematol; 2002 Sep; 118(3):817-20. PubMed ID: 12181051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density assessment in benign and malignant endometrial changes.
    Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
    Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
    Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue.
    Eshghyar N; Mohammadi N; Rahrotaban S; Motahhary P; Vahedi Vaez SM
    Arch Iran Med; 2011 Jul; 14(4):276-80. PubMed ID: 21726105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.
    Marioni G; Marino F; Giacomelli L; Staffieri C; Mariuzzi ML; Violino E; De Filippis C
    Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma.
    Zvrko E; Mikic A; Vuckovic L
    Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
    Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
    World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y; Kubota T; Takeuchi H; Sato K
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma.
    Marioni G; D'Alessandro E; Giacomelli L; Staffieri A
    J Oral Pathol Med; 2010 May; 39(5):361-7. PubMed ID: 20537053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
    Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
    Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.